Inalways (5398) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.012x

Based on the latest financial reports, Inalways (5398) has a cash flow conversion efficiency ratio of -0.012x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$-6.61 Million ≈ $-208.16K USD) by net assets (NT$530.62 Million ≈ $16.72 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Inalways (5398) net asset quality to measure how much of total assets are equity-financed.

Inalways - Cash Flow Conversion Efficiency Trend (2015–2025)

This chart illustrates how Inalways's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 5398 operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.

Inalways Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Inalways ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Tontek Design Technology Ltd
TWO:5487
0.022x
Adler Group SA
XETRA:ADJ
0.314x
AYS Ventures Bhd
KLSE:5021
0.016x
Fangdd Network Group Ltd
NASDAQ:DUO
-0.047x
Lakes Oil NL
AU:LKO
0.000x
Vyne Therapeutics Inc
NASDAQ:VYNE
-0.136x
De.Mem Ltd
AU:DEM
0.064x
CCID Consulting Company Limited
F:CCX
N/A

Annual Cash Flow Conversion Efficiency for Inalways (2015–2025)

The table below shows the annual cash flow conversion efficiency of Inalways from 2015 to 2025. For the full company profile with market capitalisation and key ratios, see how much is Inalways worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 NT$530.62 Million
≈ $16.72 Million
NT$9.14 Million
≈ $288.02K
0.017x +139.91%
2024-12-31 NT$546.17 Million
≈ $17.21 Million
NT$-23.58 Million
≈ $-742.90K
-0.043x -171.14%
2023-12-31 NT$504.59 Million
≈ $15.90 Million
NT$30.62 Million
≈ $964.76K
0.061x +246.17%
2022-12-31 NT$539.52 Million
≈ $17.00 Million
NT$-22.40 Million
≈ $-705.72K
-0.042x -122.66%
2021-12-31 NT$562.96 Million
≈ $17.74 Million
NT$103.15 Million
≈ $3.25 Million
0.183x +1710.75%
2020-12-31 NT$566.84 Million
≈ $17.86 Million
NT$-6.45 Million
≈ $-203.15K
-0.011x -147.41%
2019-12-31 NT$560.74 Million
≈ $17.67 Million
NT$13.45 Million
≈ $423.84K
0.024x +2286.81%
2018-12-31 NT$530.49 Million
≈ $16.71 Million
NT$-582.00K
≈ $-18.34K
-0.001x -100.63%
2017-12-31 NT$627.01 Million
≈ $19.75 Million
NT$108.36 Million
≈ $3.41 Million
0.173x +486.84%
2016-12-31 NT$605.72 Million
≈ $19.08 Million
NT$-27.06 Million
≈ $-852.57K
-0.045x -41.71%
2015-12-31 NT$292.23 Million
≈ $9.21 Million
NT$-9.21 Million
≈ $-290.26K
-0.032x --

About Inalways

TWO:5398 Taiwan Drug Manufacturers - Specialty & Generic
Market Cap
$22.05 Million
NT$699.94 Million TWD
Market Cap Rank
#24737 Global
#1543 in Taiwan
Share Price
NT$14.15
Change (1 day)
-2.41%
52-Week Range
NT$14.10 - NT$30.65
All Time High
NT$47.05
About

Mediera Corporation manufactures electronic and power supply components in Taiwan. It is also involved in the medical biotechnology business. The company offers medicines, health food, and medical device, etc. Mediera Corporation was founded in 1967 and is based in New Taipei City, Taiwan.